For pharmaceutical and medical device manufacturers, computerized systems validation is vital. The following are three areas businesses must fine tune to ensure computerized labeling systems meet the stipulations of the new GxP regulations.
To avoid delays in timelines, companies should develop IFU cleaning instructions with the worst-case clinical use and contamination method in mind.
Operating with an antiquated QMS raises your risk. Here’s what to consider when modernizing your system.
Simplifying the PMS process globally from end to end, can help medtech companies realize significant improvements across the board while keeping operating costs under control.
The agency will continue to work with companies developing diagnostics relevant to the coronavirus outbreak in an effort to rapidly bring technologies to market.
Label and packaging artwork processes play an important role in meeting compliance for EU MDR.
This series makes the argument for probability assessments in HFE/UE for medical devices and how to incorporate it into the paradigm.
Learn about the new subclass for Class I reusable devices under MDR and the necessary steps to ensure compliance.
Validation is an obstacle to implementing technology. A streamlined approach is necessary.
The agency has issued its list of the most common inspectional observations for FY 2017.